A randomised controlled trial of chewing gum to relieve thirst in chronic heart failure

niversity of Technology, Sydney0 个研究点目标入组 144 人开始时间: 2014年9月3日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1.Aged >18 years old
•2.Heart failure as either primary or secondary diagnosis (as per NHFA and ESC guidelines)
•Definition:
•CHF: Is a complex syndrome characterised by underlying cardiac dysfunction (either associated with impaired or preserved systolic function) and typical symptoms of exercise intolerance.
•CHF with diastolic dysfunction: CHF with normal or near normal left ventricular (LV) ejection fraction (EF), normal or near normal LV volume, and evidence of diastolic dysfunction (e.g. abnormal pattern of LV filling and elevated filling pressures)[R][R].
•3.On oral loop diuretics
•4.Able to safely chew and swallow
•5.Able to provide informed consent
•6.Able to read, speak and understand English

•1.On intravenous inotropes. Patients will be eligible once they have been weaned off the intravenous inotrope.
•2.Unable to provide informed consent
•3.People using chewing gum regularly
•4.Restricted chewing and/or swallowing (i.e. due to dysphagia or other impairment)

发起方

niversity of Technology, Sydney